APLIKASI METODE SIMPLEX LATICE DESIGN DALAM OPTIMASI FORMULA MINUMAN BOBA HERBAL UNTUK MENGATASI DISMENORE PADA REMAJA KONDISI PREMENSTRUAL SYNDROME

Background: Dysmenorrhea is a pain experienced during menstruation, characterized by typical symptoms like abdominal pain or cramps that can radiate to the waist, accompanied by fatigue, nausea, vomiting, and headaches. While this condition can be managed through pharmacological or non-pharmacological approaches, pharmacological therapies like NSAIDs are effective but carry a risk of side effects. Traditional herbal remedies or jamu, on the other hand, are less popular with adolescents due to their unpleasant taste and impracticality. This created a need for a more appealing and easy-to-consume herbal alternative, leading to the development of a herbal boba drink that combines turmeric, red ginger, tamarind, and honey. Objective: The Objective of this study was to determine the characteristics of alginate-chitosan boba from the optimum formula using the Simplex Lattice Design method and to assess the level of consumer preference for the herbal boba drink. Methodology : Formula optimization was conducted using the Simplex Lattice Design method with the aid of Design Expert (DX)®12 software. Formula evaluation included measuring yield production and swelling index as the primary parameters. Additionally, weight uniformity, which averaged 0.07855 grams, and a disintegration time of 30 minutesunder gastric pH conditions were determined as key physical quality parameters of the product. Results: The selected formula consisted of 0.5% alginate and 1.5% chitosan. Concusion: The optimum boba formula was characterized by an orange color, a soft yet brittle texture, a slightly strong herbal aroma, and a round shape. The sensory evaluation indicated that the product was well-accepted by respondents in terms of its color, taste, and aroma, suggesting its potential for development as a functional beverage.
Keywords: Alginate, Boba, Chitosan, Simplex Lattice Design
References: 82 (2014-2023)